Immunotherapy is a type of cancer treatment that does not target the cancer itself, unlike traditional treatments. Instead,...
Targeted therapies are designed to work against specific vulnerabilities in a cancer cell.
The targeted therapy drug venetoclax is...
For patients with pancreatic cancer, the benefits from immunotherapy treatments with immune checkpoint inhibitors or cell therapies...
Minimal residual disease (MRD) is a term commonly used with blood cancers that describes a small fraction of cancer cells that remain...
Layered on top of our genes is an additional set of information -- the epigenome, which is important for many cellular activities....
Although a tumor may start from a single cancer cell, it can eventually become millions of cells with unique characteristics. This...
All of the DNA in our cells is organized into complex structures called chromosomes, which consist of our genetic material coiled...
In the last decade, immunotherapy has become a viable treatment option for many cancer patients. Unlike radiation and chemotherapy,...
Medullary thyroid cancer is a rare cancer diagnosed in about 1,200 patients annually in the U.S. Because it’s often a silent disease,...
Studying new cancer therapies through clinical trials is essential for progress in cancer care. Phase I clinical trials are designed...
In cancer, there are often large-scale deletions, rearrangements or other disruptions to our genetic information, which lead to a...
Diagnostic imaging is a powerful tool for clinicians and researchers to see cancer in the body, enabling them to distinguish between...
Does social distancing effectively prevent the spread of SARS-CoV-2, the virus that causes COVID-19?
New research from MD Anderson...
After completing a course of treatment, there are few words that sound better to a patient than “complete remission.” It’s an...